GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Regeneron Pharmaceuticals, Inc. (REGN) [hlAlert]

Rating:
Perform REGN
up 127.32 %

Regeneron Pharmaceuticals, Inc. (REGN) rated Perform with price target $325 by Oppenheimer

Posted on: Thursday,  Feb 13, 2014  8:25 AM ET by Oppenheimer

Oppenheimer rated Perform Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) on 02/13/2014. Previously Oppenheimer rated Outperform Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) on 08/22/2013.,
when the stock price was $236.67. Since then, Regeneron Pharmaceuticals, Inc. has gained 127.32% as of 01/27/2016's recent price of $538.00.
If you would have followed the previous Oppenheimer's recommendation on REGN, you would have gained 127.32% of your investment in 888 days.

Regeneron Pharmaceuticals Inc. is a biopharmaceutical company that discovers, develops, and intends to commercialize therapeutic drugs for thetreatment of serious medical conditions. Regeneron's platform technologies include Targeted GenomicsTM, FunctionomicsTM, and Designer Protein TherapeuticsTM. Regeneron has drugs in clinical and preclinical development for the potential treatment of obesity, rheumatoid arthritis, cancer, allergies, asthma, amyotrophic lateral sclerosis, constipating conditions, ischemia, and other diseases and disorders. (PRESS RELEASE)

OppenheimerFunds, Inc. has been helping investors achieve their financial goals since 1960. We are one of the nation's largest and most respected asset management companies. At OppenheimerFunds, we believe that in order for you to reach your financial goals, your investments must perform. That is why investment excellence—over the long term and across the range of our products—is our highest priority. OppenheimerFunds and its controlled affiliates offer a broad range of products and services to individuals, corporations and institutions, including mutual funds, separately managed accounts, investment management for institutions, hedge fund products, qualified retirement plans and subadvisory investment-management services.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
2/13/2014 8:25 AM Buy
None
326.98 325.00
as of 10/17/2014
1 Week up  7.60 %
1 Month up  2.93 %
3 Months up  24.70 %
1 YTD up  34.29 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
9/30/2013 8:25 AM Buy
None
303.00 310.00
8/22/2013 8:25 AM Buy
None
236.67 300.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy